Clean Science Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
309.00
356.00
326.00
395.00
304.00
267.00
Adjustment
57.00
41.00
13.00
21.00
12.00
6.00
Changes In working Capital
-1.00
-88.00
-27.00
-42.00
-120.00
-14.00
Cash Flow after changes in Working Capital
365.00
309.00
311.00
373.00
196.00
258.00
Cash Flow from Operating Activities
274.00
213.00
236.00
279.00
127.00
192.00
Cash Flow from Investing Activities
-202.00
-152.00
-185.00
-269.00
-78.00
-186.00
Cash Flow from Financing Activities
-63.00
-52.00
-53.00
-55.00
0.00
-5.00
Net Cash Inflow / Outflow
8.00
9.00
-1.00
-45.00
48.00
0.00
Opening Cash & Cash Equivalents
19.00
10.00
12.00
57.00
9.00
9.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
28.00
19.00
10.00
12.00
57.00
9.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Clean Science
Figures in Cr
standaloned Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
335.61
198.54
137.00
69.04%
Adjustment
26.63
-16.97
42.00
256.92%
Changes In working Capital
38.85
-14.32
52.00
371.30%
Cash Flow after changes in Working Capital
401.08
167.24
234.00
139.82%
Cash Flow from Operating Activities
309.88
127.11
182.00
143.79%
Cash Flow from Investing Activities
-243.75
-194.35
-49.00
-25.42%
Cash Flow from Financing Activities
-63.52
-6.41
-57.00
-890.95%
Net Cash Inflow / Outflow
2.61
-73.65
75.00
103.54%
Opening Cash & Cash Equivalents
14.82
139.62
-125.00
-89.39%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
17.42
65.97
-48.00
-73.59%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 28.38% vs -9.56% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
274.52
213.84
28.38%






